The standard 0.5 mg starting protocol A 0.5 mg weekly starting dose has become increasingly popular outside of formal clinical trials
5 GLP-1 RAs come in different doses with equally variable lasting effects and molecular structures, making it possible to formulate tailored treatment regimens based on patient needs and preferences
Wegovy / Ozempic) Semaglutide is a potent, long-acting GLP-1 RA available as a weekly injectable
More recently, the SELECT trial showed that semaglutide 2.4 mg reduced major adverse cardiovascular events in adults with overweight or obesity without diabetes
Thus, we further explored whether GLP-1R is involved in CM by mediating microglial activation, including morphological changes and inflammation
If you have struggled with weight despite diet and exercise, medical therapies may offer the support you need